|

Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study

RECRUITINGN/ASponsored by Ottawa Hospital Research Institute
Actively Recruiting
PhaseN/A
SponsorOttawa Hospital Research Institute
Started2025-07-21
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol/L), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time. The two study interventions that the participant can choose to complete (one or both interventions). Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities, and choose one of 4 capillary blood glucose recheck times.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  1. Consent provided
  2. Age \>= 18 years.
  3. Diagnosed as type 2 diabetes mellitus.
  4. Type 2 diabetes medications include at least one of the following for at least one month prior to entering the study: sulfonylurea or insulin of any type.

Exclusion Criteria:

* An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Diagnosed as another form of diabetes mellitus.
  2. Has a history of hypoglycemia unawareness.
  3. Had a hypoglycemia event, defined as capillary blood glucose \< 3.9 mmol/L within 24 hours prior to the study visit booking time.

Conditions3

DiabetesHypoglycemia (Diabetic)Type 2 Diabetes (T2DM)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.